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Abstract
Objective—Chronic disease collaboratives help practices redesign care delivery. The North
Carolina Improving Performance in Practice program provides coaches to guide implementation
of 4 key practice changes: registries, planned care templates, protocols, and self-management
support. Coaches rate progress using the Key Drivers Implementation Scales (KDIS). This study
examines whether higher KDIS scores are associated with improved diabetes outcomes.
Methods—We analyzed clinical and KDIS data from 42 practices. We modeled whether higher
implementation scores at year 1 of participation were associated with improved diabetes measures
during year 2. Improvement was defined as an increase in the proportion of patients with
hemoglobin A1C values <9%, blood pressure values <130/80 mmHg, and low-density lipoprotein
(LDL) levels <100 mg/dL.
Results—Statistically significant improvements in the proportion of patients who met the LDL
threshold were noted with higher “registry” and “protocol” KDIS scores. For hemoglobin A1C
and blood pressure values, none of the odds ratios were statistically significant.
Conclusions—Practices that implement key changes may achieve improved patient outcomes in
LDL control among their patients with diabetes. Our data confirm the importance of registry
implementation and protocol use as key elements of improving patient care. The KDIS tool is a
pragmatic option for measuring practice changes that are rooted in the Chronic Care Model.
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The US health system requires substantial change to deliver safe, efficient, and effective
patient care.1 In the 2001 Crossing the Quality Chasm report, the Institute of Medicine
specifically states that systems must be “redesigned” because existing systems fail to
support high-quality care for chronic diseases. To aid in redesign efforts, national and state-
level organizations have created programs in which practice staff and providers receive
instruction and assistance in implementing quality improvement (QI) strategies in their
clinical settings.2–8 Such programs often are called chronic disease collaboratives; teams of
clinicians and office staff are taught experientially how to implement key drivers of practice
changes that are rooted in the Chronic Care Model (CCM).9,10
To date, observational studies regarding the impact of collaborative participation on
outcomes suggest that participation can positively affect some process and outcome
measures.3–5,7,9 However, since collaboratives involve simultaneously learning many new
skills and implementing several facets of chronic disease care, it is challenging to tease out
which specific facets are of value.11 In addition, how well such activities are actually
implemented in clinical settings is poorly understood in clinical research,12,13 and the
Patient Centered Outcomes Research Institute has identified implementation challenges as a
key barrier to the widespread adoption of potentially effective interventions.14
To both overcome barriers to adoption and accurately assess the effectiveness of an
intervention, measures are needed that validly and reliably capture how well interventions
are implemented at the organizational level.15 Although some work has been done to create
such implementation measures in evaluations of chronic care collaboratives, this work was
done several years after the work in the practices commenced.12,16 Thus, to date there is
little information linking prospectively collected implementation assessments with
improvements in patient outcomes.
Using a sample of practices involved in the North Carolina Improving Performance in
Practice (IPIP) program, a statewide QI project in North Carolina, we examined whether the
extent of implementation of 4 key drivers of practice change was associated with improved
population-level outcomes for diabetes care as indicated by measures of serum
glycohemoglobin (A1C), low-density lipoprotein (LDL), and blood pressure (BP).
Methods
Setting
The North Carolina IPIP program is a nationally supported, state-based QI program that is
rooted in the CCM.9,10 IPIP combines 2 improvement designs: a “1-to-many” or
collaborative design17 and a “1 to 1” practice coaching model design.6 By participating in
IPIP, primary care providers and staff are introduced to QI methods with the help of an
onsite QI practice coach. The practice team learns how to implement and monitor their QI
efforts and participates in learning networks with peer organizations that share practice
improvement strategies. All primary care practices in North Carolina are eligible to
participate in the IPIP program. Practices receive $2000 for participating and providers can
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obtain continuing medical education credits. The work also provides a mechanism to fulfill
requirements for Part IV Maintenance of Certification.
The IPIP organization chose nationally endorsed clinical quality measures to evaluate the
impact of their diabetes QI program on the following patient population-level outcomes;
A1C, LDL, and BP. However, unlike groups like the National Committee for Quality
Assurance, which puts forth performance measurement thresholds for practices to reach,
IPIP establishes performance goals for practices to aim for based on the experiences of the
better-performing practices.
IPIP’s first year included a small cohort of practices and 2 practice coaches that could pilot
test many of the nascent program components. After evaluating experiences over the first
year, the national team, in collaboration with state-level IPIP stakeholders and international
experts in systems improvement, agreed that a more formal guidance document, called a
change package, was essential to enabling the change processes within practices. To provide
a measurement tool to capture the implementation of change package activities, the IPIP
leadership simplified and sequenced 6 elements of the CCM to 4 key drivers of practice
change,6 resulting in the development of the Key Driver Implementation Scales (KDIS).
The KDIS ordinal ratings are used by practice coaches to document a practice’s adoption
and the extent of implementation of the 4 key drivers on a monthly basis. The KDIS
prospectively captures the extent of implementation of (1) a disease registry, (2) the use of
planned care templates to standardize items that are addressed with every diabetic patient at
every visit, (3) comprehensive care protocols to guide global diabetic care beyond what is
just included in the planned care templates, and (2) self-management support (SMS) systems
within a practice. In general, a KDIS score of 0 indicates that the practice has had no activity
in the respective practice change variable, while a 1 indicates that a particular item, such as a
type of registry or a specific planned care template, has been selected for use in the practice.
A score of 2 signifies that staff roles for an activity have been assigned or that an item such
as a disease registry has been installed. A score of 3 signals that a practice is actually testing
an item, while a 4 indicates that a large percentage of the practice is using the item. Practice-
wide dissemination is indicated by a score of 5. A sample of the scale, limited to the registry
item, is provided in Table 1. A full description of the key drivers and scale are available at
forces4quality.org/af4q/download-document/3470/960.
The practice coaches assign the first KDIS scores soon after getting started with a new
practice and subsequently submit these data each month to the state director. When the
KDIS was first created, it was generally expected that the practices would focus on the 4 key
drivers in sequence, starting with the development of a disease registry, followed by the use
of a care protocol and planned care templates, and then finally development of SMS tools
for patients, with the understanding that overlap of these concepts exists and that practices
start at different levels along the improvement continuum. The sequencing of
implementation was for starting, not finishing, work on one element of practice change.
The KDIS scores not only allow for individual and aggregate practice data review but also
provide data to the IPIP program leadership for use in continuous evaluation of the program.
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The scores also can be used to demonstrate to program funding agencies that practice-level
changes are occurring and are doing so at a time far earlier than when patient-level outcome
measures can be generated. To quote a key IPIP stakeholder, the KDIS scores capture
practice changes that occur “while the clinical data are catching up.”
Data Sources
We collected 2 sets of data for 42 practices that participated in the diabetes track of the IPIP
program, starting in February 2008 or later: (1) monthly KDIS scores, as described above,
and (2) monthly population-level clinical data that included numerators and denominators
used to calculate the percentage of a practice’s diabetic patients whose values of A1C were
<9%, LDL <100 mg/dL, and in-office BP measurements <130/80 mmHg.
Analysis
To be included in our analysis, practices needed to have (1) participated with a practice
coach for at least 13 months starting in February 2008 or beyond, (2) submitted clinical data
reports in months 10, 11, or 12, and (3) submitted another clinical data report at some point
during their second year of participation with their coach. Our data collection timeline is
presented in Figure 1.
For our analysis we calculated a KDIS score representing the score at year 1 for each of the
4 key drivers within each clinic. To reduce the effect of a spurious outcome and missing
values, this score represents the average of an individual practice’s KDIS scores at months
10, 11, and 12. The distribution of 1-year scores among the 42 practices is represented in
Figure 2.
To test for associations between the year 1 score and subsequent improvements in
population-level clinical outcomes, we created for each outcome a model to estimate
whether higher KDIS scores at the year 1 mark were associated with subsequent
improvements in a practice’s clinical data during the second year of IPIP participation.
Improved clinical data were defined as any increase in the proportion of diabetic patients
with hemoglobin A1C levels <9%, BP values <130/80 mm Hg, and LDL levels <100 mg/dL
during the second year of practice coach involvement. Within the model, this increase can
be detected through an odds ratio of >1.
In our model we controlled for clinical outcomes at the end of year 1. We used the means of
the clinical outcomes measures at months 10, 11, 12, again choosing a range of time points
for robustness and to capture data that suggested practice engagement with a practice coach
for at least 1 year. We also included time and the interaction between time and the KDIS
scores to capture changes in the association between KDIS scores and clinical outcome over
time. We ran a repeated measures logistic regression to account for the repeated measures
within clinics over time. The outcome variable was the proportion of patients who met a
clinical threshold out of the total number of eligible patients seen (eg, those with diabetes).
We clustered the data analysis at the practice level and across time using the method
described by Williams. 18 This structure assumes that within-clinic model residuals closer in
time are more highly correlated than those further apart. Model estimates were used to
construct odds ratios of improvement in clinical outcomes, defined as an increase in the
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proportion of patients meeting a clinical threshold from year 1 to year 2. Because of how we
applied our eligibility criteria and created out analytical model, there were no missing data
other than for one practice that did not report LDL data. This practice was not included
when we ran the model for LDL improvement by level of KDIS implementation. All
analyses were done using SAS software version 9.2 (SAS Institute Inc., Cary, NC). The
Biomedical Institutional Review Board at the University of North Carolina reviewed and
approved this project.
Results
The demographics of the 42 practices included in the model are listed in Table 2. Of note,
43% of the practices had ≤3 providers; 73% were staffed by family practitioners and, on
average, 23% of patients were covered by Medicaid. Of all the practices, 62% were located
in rural counties in North Carolina. To provide some context regarding the study practices’
starting points with regard to their clinical diabetes data, we also calculated the number of
the practices whose data would have made them eligible for recognition in the Diabetes
Recognition Program supported by the National Committee on Quality Assurance and the
number that reached organization-specific goals for these measures set by IPIP.
The distribution of KDIS scores as measured at the end of 1 year of engagement with a
practice coach is presented in Figure 2. A greater number of practices were able to achieve
deeper implementation of some key driver elements more than others. For example, 31 of 42
practices achieved a KDIS score of ≥3 on the registry item by the end of 1 year, while only
15 of 42 were able to achieve a KDIS score of ≥3 for the SMS item during this same time
interval. Of note, in most cases KDIS scores remained the same or improved during the
second year of participation with a practice coach (data not shown).
Table 3 reveals the odds ratios of practices with a higher percentage of their patients with
LDL clinical measures under control at the 2-year mark compared with the 1-year data.
Statistically significant improvements in the proportion of patients who met the LDL
threshold at the 2-year mark were noted for practices that achieved a KDIS score of 4 or 5
on the registry and protocol items. In accordance with this, the point estimate trends suggest
that improved LDL control is associated with increasingly higher degrees of implementation
of these activities in a dose-response relationship. When we modeled having all key drivers
increasing together (“All 4 Drivers” column in Table 2), similar improvements in the LDL
population measures are noted.
Our model also suggests that practices without any activity or improvement in the KDIS
score for the “protocol” key driver saw worsening of their LDL performance measure (Table
3). When we used the same analysis method to analyze KDIS scores against improvements
in A1C and BP values, none of the odds ratios were statistically significant, nor were there
any apparent trends (results are available from the authors on request).
Discussion
Our analysis suggests that improved outcomes for patients with diabetes may be associated
with a practice’s ability to implement key drivers of practice change. Most notable is that
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practices that implement a disease registry, use their registry data to plan patient care, and
produce performance reports by the end of a single year of involvement with IPIP may
realize improvements in population-level LDL control during the second year of
involvement. Our data also suggest that similar improvements in population-level LDL
control may be realized when disease protocols are agreed on and implemented widely
within a practice.
We did not find improvements in clinical outcomes when SMS or planned care templates
were more extensively implemented. For SMS in particular, this may be due in part to the
limited time interval we used in our analysis and the fact that the practice coaches were
instructed to guide practices to implement all 4 key drivers in sequence, with SMS
improvements being last. It is notable that the activities that conferred a score of 1 or 2 for
SMS were not those that would be expected to affect patient behavior change and thus
clinical outcome data. As noted in Figure 2, the vast majority of practices received KDIS
scores of 0, 1, or 2, indicating that practices either had no efforts at SMS during year 1 or
were just in the early planning periods of rolling out SMS activities.
Aside from having a small sample size and inadequate power, we cannot explain why there
were no signals in the data to indicate that the use of planned care templates may be
associated with improved clinical outcomes, as seen elsewhere in the literature.11 The
current leadership of the IPIP organization continues to feel that all 4 key drivers are crucial
and independently important items for securing practice change. Thus further evaluation of
the relationship between this specific key driver and outcomes should continue as greater
numbers of practices make progress on implementation.
It is unclear why our results indicate an improvement in population-level LDL control but
not control of A1C and/or BP. Other investigators have used these same outcome measures
in cohort designs to study the effect of QI interventions and found no improvement in any of
these 3 variables,19 improvements in LDL and BP but not A1C,20 or improvements in A1C
and BP but not LDL.21 Improving patient- or population-level clinical outcomes involves
complex issues that rely on patient-, practice-, and system-level factors, and partial
implementation of key drivers may have only small effects on outcome measures. However,
improved lipid control at a population level is noteworthy, and future evaluations should
attempt to uncover why certain outcome measures improve faster or to a greater extent than
others.
Our data add further support to the importance of registry implementation and the institution
of care protocols as key elements of improving patient care. Perhaps that a practice can
develop and meaningfully use a patient registry, disease protocols, or both represents a host
of contextual factors or surrogate measures that indicate a practice’s potential to affect
patient outcomes. Evaluating implementation of these key drivers over a longer period of
time may allow us to determine whether other key drivers have important effects on patients
outcomes.
Since prior studies indicate that the improvement process is long and slow22,23 and requires
tremendous effort,24 our limited findings of association between patient outcomes and the
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KDIS’s key driver measures suggest promise for the KDIS tool for measuring practice
transformation and implementation. Programs such as IPIP, which support practice
transformation, need strategies to assess implementation, provide timely data to program
stakeholders, and understand the success of their practice support programs. Although more
complex evaluation tools have been designed to capture this type of data,12 the KDIS tool
provides a pragmatic alternative that seems to capture meaningful practice change variation
without creating significant burden on practices or coaches. Of note, since the time of our
study, the IPIP program has evolved into the North Carolina Area Health Education Centers
Practice Support Program and has taken on an increased set of practice support
responsibilities, including assisting practices with the meaningful use of electronic health
records and patient-centered medical home initiatives. Even with these expanded
responsibilities, all 4 components of the KDIS tool are still of great value to program
leadership and continue to be used by practice support teams to measure the implementation
of key drivers.
Limitations
Our analysis is based on 42 primary care practices in a single state. With only 42 practices,
we have limited power to detect smaller implementation effects. Furthermore, none of our
clinics have ≥3 years of data, and only 16 have >2 years. Because it may take months of
work to affect the KDIS scores and even longer for clinical outcomes to change within a
practice, our data may only be able to tell us the beginning of the story. As well as a QI
project, some practice numerators and denominators reflected sample data abstractions only,
especially early on in the practices’ learning process, and thus did not reflect their full
population of diabetic patients. However, when we re-ran the LDL improvement analysis
model without including practices that used sample data, the results from the remaining 34
practices were essentially the same with regard to the implementation depth of a registry,
disease protocols, and planned care templates.
Our results may also be biased by the limitation of our study design. The North Carolina
IPIP is a QI project; thus rigorous study design was not a priority during implementation.
We do not have a comparison group or data to suggest the effect of secular trends. In
addition, we are aware of anecdotal reports from IPIP coaches that although most of the
KDIS tool and taxonomy worked well, there was sometimes confusion in understanding the
difference between “protocol” and “planned care templates,” especially when specific
electronic medical record systems and vendors used the term protocol in the manner that
IPIP used planned care templates. Finally, the types of practices that chose to undergo a QI
project may not be broadly representative of all primary care practices.
The KDIS was developed to supplement the QI work with health care delivery systems and
was not subject to the rigorous development processes typically involved in the development
of instruments, such as interrater reliability testing. However, a single trainer within the IPIP
organization provided instructions to all 9 staff who served as practice coaches during the
time interval of this study. This group continuously addressed the tool and measurement
methods as part of their monthly conference calls with the IPIP program leadership. As is
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typical of many of the QI interventions implemented by IPIP, the tool was carefully piloted
with a small number of experienced coaches before being used more broadly in the field.
Conclusions
Our work suggests that the degree of implementation of 4 key drivers of practice change
may be associated with improvement in selected outcomes for patients with diabetes. LDL
control seems most likely to change in a short time frame and to be associated most strongly
with the implementation of a patient registry and care protocols. However, patterns in our
results suggest that other important associations between practice changes and clinical
outcomes may emerge over a longer study period. Although our findings are based on a
small number of diverse practices in a single state, our work is a first step in using a
practical rating system, with roots in the CCM, to independently measure the extent of
practice change implementation. Such data will be needed for practices and practice support
programs to monitor transformation progress and for researchers and policy makers to
understand the effectiveness of practice change interventions controlling for depth of
implementation.
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Data collection timeline. BP, blood pressure; KDIS, Key Drivers Implementation Scale;
LDL, low-density lipoprotein.
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Frequency distribution of Key Drivers Implementation Scale (KIDS) scores attained at 1
year (with averages across months 10, 11, and 12) after coaching commenced by key driver.
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Table 1
Sample of Registry Item of the Practice Assessment Scales/Key Driver Implementation Scale* in Improving
Performance in Practice
Item No. Item Title Description
0 No activity There has been no activity on registry adoption or use.
1 Selected The practice has chosen a registry but has not yet begun using it.
2 Installed The practice has a registry installed on a computer and has set up a template, and entered demographic data
on patients of interest (e.g., diabetes) or has outlined a process to systematically enter the data.
3 Testing workflow The practice is testing the process for entering clinical data into the registry but is not yet using the registry
to help with the daily care of patients.
4 Patient management All clinical data is entered into the registry and the practice is using the registry daily to plan patient care
and is able to produce consistent reports on population performance.
5 Full integration Registry is kept up to date with a consistent and reliable process. The practice checks on and monitors the
registry processes and uses the registry to manage the entire patient population.
For the full scale see http://forces4quality.org/sites/default/files/tool6.1ipippractice%20assessment%20template.pdf.
*
The Key Driver Implementation Scale term is that used by the investigators of the Transforming Primary Care Practice in North Carolina (AHRQ
R18 HS019131).
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Table 2
Practice Characteristics (n = 42)
Characteristic Practices*
Service area
  Rural 26 (62)
  Urban 16 (38)
Mean provider count (n) 8.4
Providers (n)
  ≤3 18 (43)
  4–6 13 (31)
  ≥7 11 (26)
Practice specialty
  Family medicine 31 (73)
  Internal medicine 9 (21)
  Mixed (internal/family medicine) 2 (5)
Practice type
  Nonacademic 37 (74)
  Academic 5 (12)
Insurance† (mean %)
  Medicaid (n = 35) (23)
  Uninsured (n = 33) (18)
Practice visits per day (n = 37), n (range) 73.6 (10–345)
Uses electronic health record system 22 (52)
Study practices with baseline clinical data that reached NCQA Diabetes Recognition Program performance thresholds
  LDL levels‡ < 100 mg/dL 23 (37)
  Systolic blood pressure 31 (36)
  Hemoglobin A1C 17 (27)
Study practices that reached IPIP goals (n)
  LDL levels‡ < 100 mg/dL 1
  Systolic blood pressure 1
  Hemoglobin A1C 4
Data are n (%) unless otherwise indicated.
*
Percentages listed may reflect rounding.
†
Insurance and practice visit data for several practices are missing.
‡
One practice did not have data for low-density lipoprotein (LDL) levels.
NCQA, National Committee for Quality Assurance; IPIP, Improving Performance in Practice.
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